EyePoint Pharmaceuticals, Inc. (EYPT) Q4 2020 Earnings Conference Call March 4, 2021 8:30 AM ET Company Participants George Elston – Chief Financial Officer Nancy Lurker – President and Chief Executive Officer Jay Duker – Chief Strategic Scientific Officer Scott Jones – Chief Commercial Officer Dario Paggiarino – Senior Vice President and Chief Medical Officer Conference Call Participants Jennifer Kim – Cantor Fitzgerald Dana Flanders – Guggenheim Yale Jen – Laidlaw and Company Andrew D'Silva – B. Riley Presentation Operator Good morning. My name is Kevin and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals’ Fourth Quarter and Year End 2020 Financial Results and Recent Corporate Development Conference Call. There will be a question-and-answer session to follow with the completion of the prepared remarks. Please be advised that this call is being recorded at the company's request. I would now

For further details see:

EyePoint Pharmaceuticals' (EYPT) CEO Nancy Lurker on Q4 2020 Results - Earnings Call Transcript